Return to content in this issue

 

Efficacy and safety of nemolizumab for adult atopic dermatitis treatment: A meta-analysis of randomized clinical trials

Xuemin X1*, Lihang L1*, Changhua Z1, Xiaofang Y1, Yongshan N1, Zhipeng L1, Chong J2, Yue H1

1Department of Dermatology, the Union Hospital, Fujian Medical University, Fuzhou, P.R. China
2College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, P.R. China
*These authors contributed to the work equally.

J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0672

Key words: Nemolizumab, Meta-analysis, Atopic dermatitis, Efficacy, Safety